Tamer I. Khayal, Chief Commercial Officer at TransMedics Group, Inc. (TMDX), sold 4,660 shares at $90.09 ($420K) on 2024-01-23, disclosed to the SEC on 2024-01-25.
Scheduled sale ($420k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.09 | 2,330 | $210K | 50.0% |
| 2 | $90.09 | 2,330 | $210K | 50.0% |
| Total | $90.09 avg | 4,660 | $420K | 100% |
| Filing → |
| TMDX | SELL | 2024-12-04 | $187K | — | Filing → |
| TMDX | SELL | 2024-11-13 | $263K | — | Filing → |
| TMDX | SELL | 2024-11-05 | $179K | — | Filing → |